Phase Ib / Iia Clinical Trial, dose-blind, single-blind, to evaluate the safety of intravenous administration of expanded allogenic mesenchymal stem cells derived from adipose tissue to patients with refractory rheumatoid arthritis (RA)
Pathology and candidate patients
Dr. Luís Martí Bonmatí
Hospital Quirónsalud Valencia.
If you are interested in this clinical trial because you believe that you or a family member of yours can benefit from this new treatment.
You can request a consultation with the image diagnosis team by sending an email to the address: email@example.com